Danaher Corporation (DHR) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Key Points Company and Industry Information 1. Company: Danaher Corporation (NYSE:DHR) 2. Event: 43rd Annual J.P. Morgan Healthcare Conference 3. Date: January 14, 2024 4. Time: 2:15 PM ET 5. Participants: - Rainer Blair - President and Chief Executive Officer of Danaher Corporation - Rachel Vatnsdal - J.P. Morgan [1] Core Views and Arguments 1. Fourth Quarter 2024 Results: - Revenue is expected to be essentially flat. - Bioprocessing business is in line with expectations. - Diagnostics segment slightly above expectations due to higher respiratory sales at Cepheid. - Life Sciences segment had modestly better-than-anticipated revenue driven by strong instrumentation sales. [3] 2. Adjusted Operating Profit Margin: - Expected to be consistent with prior guidance. - Better-than-expected operational performance offset by foreign exchange. [4] 3. Overall 2024 Performance: - Danaher generated $24 billion of revenue across three segments and 15 operating companies. - Operating companies are global franchises with large market presence. [4]